Seeber S - Search Results

1

Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities.

Sarbia M, Stahl M, Fink U, Heep H, Dutkowski P, Willers R, Seeber S, Gabbert HE. Sarbia M, et al. Among authors: seeber s. Int J Cancer. 1999 Feb 19;84(1):86-91. doi: 10.1002/(sici)1097-0215(19990219)84:1<86::aid-ijc16>3.0.co;2-7. Int J Cancer. 1999. PMID: 9988238

2

Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.

Niederle N, Schütte J, Schmidt CG, Seeber S. Niederle N, et al. Among authors: seeber s. Cancer Treat Rep. 1984 May;68(5):791-2. Cancer Treat Rep. 1984. PMID: 6327037

3

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H. Stahl M, et al. Among authors: seeber s. J Clin Oncol. 2005 Apr 1;23(10):2310-7. doi: 10.1200/JCO.2005.00.034. J Clin Oncol. 2005. PMID: 15800321 Clinical Trial.

4

Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer.

Stahl M, Wilke H, Stuschke M, Walz MK, Fink U, Molls M, Siewert JR, Schroeder M, Makoski HB, Schmidt U, Seeber S, Vanhoefer U. Stahl M, et al. Among authors: seeber s. J Cancer Res Clin Oncol. 2005 Jan;131(1):67-72. doi: 10.1007/s00432-004-0604-5. Epub 2004 Oct 5. J Cancer Res Clin Oncol. 2005. PMID: 15480782 Clinical Trial.

5

10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL).

Eberhardt WE, Gauler TC, Lepechoux C, Stamatis G, Bildat S, Krbek T, Welter S, Grunenwald D, Fischer B, Rodrigo Hde L, Theegarten D, Le Chevalier T, Seeber S, Stuschke M, Poettgen C. Eberhardt WE, et al. Among authors: seeber s. Lung Cancer. 2013 Oct;82(1):83-9. doi: 10.1016/j.lungcan.2013.06.007. Epub 2013 Aug 16. Lung Cancer. 2013. PMID: 23957964 Clinical Trial.

6

Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors, including colorectal cancer.

Kupsch P, Henning BF, Passarge K, Richly H, Wiesemann K, Hilger RA, Scheulen ME, Christensen O, Brendel E, Schwartz B, Hofstra E, Voigtmann R, Seeber S, Strumberg D. Kupsch P, et al. Among authors: seeber s. Clin Colorectal Cancer. 2005 Sep;5(3):188-96. doi: 10.3816/ccc.2005.n.030. Clin Colorectal Cancer. 2005. PMID: 16197622 Clinical Trial.

7

Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.

Bauer S, Hartmann JT, de Wit M, Lang H, Grabellus F, Antoch G, Niebel W, Erhard J, Ebeling P, Zeth M, Taeger G, Seeber S, Flasshove M, Schütte J. Bauer S, et al. Among authors: seeber s. Int J Cancer. 2005 Nov 1;117(2):316-25. doi: 10.1002/ijc.21164. Int J Cancer. 2005. PMID: 15900603 Clinical Trial.

8

The Raf kinase inhibitor BAY 43-9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines.

Heim M, Scharifi M, Zisowsky J, Jaehde U, Voliotis D, Seeber S, Strumberg D. Heim M, et al. Among authors: seeber s. Anticancer Drugs. 2005 Feb;16(2):129-36. doi: 10.1097/00001813-200502000-00003. Anticancer Drugs. 2005. PMID: 15655409

9

Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy.

Kasimir-Bauer S, Mayer S, Bojko P, Borquez D, Neumann R, Seeber S. Kasimir-Bauer S, et al. Among authors: seeber s. Clin Cancer Res. 2001 Jun;7(6):1582-9. Clin Cancer Res. 2001. PMID: 11410494

10

Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell lines.

Harstrick A, Vanhoefer U, Schleucher N, Schroeder J, Baumgart J, Scheulen ME, Wilke H, Seeber S. Harstrick A, et al. Among authors: seeber s. Anticancer Drugs. 1995 Oct;6(5):681-5. doi: 10.1097/00001813-199510000-00007. Anticancer Drugs. 1995. PMID: 8845478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results